Dear Editor, It is important to note as the article that the Doctors’ pay has declined in real terms over the past 15 years, with resident doctors down 8.6% and consultants down ...

Research suggests the drugs have potential for prevention and harm reduction in substance use disorders, writes Ziyad Al-Aly People taking glucagon-like peptide-1 (GLP-1) receptor agonists often ...

As public health officials warn about rising emissions from urban wood burning, a BMJ investigation finds that just under a third of councils in high use areas have faced pressure from the stove ...

Tom Nolan reviews this week’s research Much is made of how large language models (LLMs) can pass medical licensing exams with ...

Health workers and facilities have come under attack across the Middle East as conflict engulfs the region, health leaders and charities warn. The International Committee of the Red Cross (ICRC), ...

Clinical trials and equitable care pathways are needed to build on early evidence of benefit Substance use disorders (SUDs) are common and burdensome for patients, families, and health systems,12 yet ...

I found myself unusually narked this month. Not by a long night shift or a difficult airway, but by governance. I was trying ...

New research indicates that the levels of microplastics in humans and the environment may have been overestimated. So, should we still be concerned about their possible health effects? Katharine Lang ...

A bill promising to prioritise UK trained medical graduates for training places has become law. However, doctors’ leaders say questions remain over international medical graduates (IMGs) and the ...

Chris Whitty is wrong to argue that debate on the PATHWAYS trial of puberty blockers in children should be left to specialists. The trial raises deep and important questions: ...

When the powers that be at King’s College Hospital told neurosurgeon Charles Polkey that it had decided to name a ward after him he was initially reluctant to accept the honour. He only relented after ...

President Donald Trump has issued an executive order aiming to increase domestic production of the controversial weedkiller glyphosate, sold as Roundup.1 Trump’s 18 February order comes under a ...